| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells
|
Togano, Tomiteru
|
|
2014
|
83 |
2 |
p. 139-145
7 p.
|
artikel
|
| 2 |
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma
|
Cao, Christopher
|
|
2014
|
83 |
2 |
p. 240-245
6 p.
|
artikel
|
| 3 |
Bilateral ovarian metastasis of non-small cell lung cancer with ALK rearrangement
|
Fujiwara, Ayako
|
|
2014
|
83 |
2 |
p. 302-304
3 p.
|
artikel
|
| 4 |
Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer
|
Kaira, Kyoichi
|
|
2014
|
83 |
2 |
p. 197-204
8 p.
|
artikel
|
| 5 |
Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma
|
Sun, Jong-Mu
|
|
2014
|
83 |
2 |
p. 259-264
6 p.
|
artikel
|
| 6 |
Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment
|
Kim, Hye-Ryoun
|
|
2014
|
83 |
2 |
p. 252-258
7 p.
|
artikel
|
| 7 |
Clinicopathological characteristics and surgical results of lung cancer patients aged up to 50 years: The Japanese Lung Cancer Registry Study 2004
|
Inoue, Masayoshi
|
|
2014
|
83 |
2 |
p. 246-251
6 p.
|
artikel
|
| 8 |
Contents
|
|
|
2014
|
83 |
2 |
p. v-vi
nvt p.
|
artikel
|
| 9 |
Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)
|
Tiseo, Marcello
|
|
2014
|
83 |
2 |
p. 265-271
7 p.
|
artikel
|
| 10 |
Dramatic response to high-dose icotinib in a lung adenocarcinoma patient after erlotinib failure
|
Guan, Yin
|
|
2014
|
83 |
2 |
p. 305-307
3 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2014
|
83 |
2 |
p. iii-
1 p.
|
artikel
|
| 12 |
EGFR mutation frequency and effectiveness of erlotinib: A prospective observational study in Danish patients with non-small cell lung cancer
|
Weber, Britta
|
|
2014
|
83 |
2 |
p. 224-230
7 p.
|
artikel
|
| 13 |
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)
|
Yang, James Chih-Hsin
|
|
2014
|
83 |
2 |
p. 174-181
8 p.
|
artikel
|
| 14 |
Historical perspectives: The evolution of the thymic epithelial tumors staging system
|
Filosso, Pier Luigi
|
|
2014
|
83 |
2 |
p. 126-132
7 p.
|
artikel
|
| 15 |
How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?
|
Bayman, Neil
|
|
2014
|
83 |
2 |
p. 117-125
9 p.
|
artikel
|
| 16 |
Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study)
|
Toffart, Anne-Claire
|
|
2014
|
83 |
2 |
p. 182-188
7 p.
|
artikel
|
| 17 |
KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
|
Maus, M.K.H.
|
|
2014
|
83 |
2 |
p. 163-167
5 p.
|
artikel
|
| 18 |
Low physical activity levels and functional decline in individuals with lung cancer
|
Granger, Catherine L.
|
|
2014
|
83 |
2 |
p. 292-299
8 p.
|
artikel
|
| 19 |
Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer
|
Pujol, Jean-Louis
|
|
2014
|
83 |
2 |
p. 211-218
8 p.
|
artikel
|
| 20 |
Methylation and expression profiles of MGMT gene in thymic epithelial tumors
|
Mokhtar, Mohamed
|
|
2014
|
83 |
2 |
p. 279-287
9 p.
|
artikel
|
| 21 |
MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells
|
Ho, Chai San
|
|
2014
|
83 |
2 |
p. 154-162
9 p.
|
artikel
|
| 22 |
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
|
Li, Bing
|
|
2014
|
83 |
2 |
p. 146-153
8 p.
|
artikel
|
| 23 |
NF-κB protein expression associates with 18F-FDG PET tumor uptake in non-small cell lung cancer: A radiogenomics validation study to understand tumor metabolism
|
Nair, Viswam S.
|
|
2014
|
83 |
2 |
p. 189-196
8 p.
|
artikel
|
| 24 |
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
|
Mescam-Mancini, Lénaïg
|
|
2014
|
83 |
2 |
p. 168-173
6 p.
|
artikel
|
| 25 |
Outcome of surgically resected thymic carcinoma: A multicenter experience
|
Filosso, Pier Luigi
|
|
2014
|
83 |
2 |
p. 205-210
6 p.
|
artikel
|
| 26 |
Positive prognostic impact of miR-210 in non-small cell lung cancer
|
Eilertsen, Marte
|
|
2014
|
83 |
2 |
p. 272-278
7 p.
|
artikel
|
| 27 |
Radiotherapy for the treatment of pain in malignant pleural mesothelioma: A systematic review
|
MacLeod, N.
|
|
2014
|
83 |
2 |
p. 133-138
6 p.
|
artikel
|
| 28 |
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
|
Stephenson, Joe J.
|
|
2014
|
83 |
2 |
p. 219-223
5 p.
|
artikel
|
| 29 |
Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials
|
Shi, Liang
|
|
2014
|
83 |
2 |
p. 231-239
9 p.
|
artikel
|
| 30 |
Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation
|
Villaruz, Liza C.
|
|
2014
|
83 |
2 |
p. 300-301
2 p.
|
artikel
|
| 31 |
Thoracic tumor effects on plasmatic coagulation: Role of hemeoxygenase-1
|
Nielsen, Vance G.
|
|
2014
|
83 |
2 |
p. 288-291
4 p.
|
artikel
|
Tijdschrift beschrijving